3,4-Dihydroxyphenylacetic acid
ALDRICH/850217 - 98%
Synonym: DOPAC; Homoprotocatechuic acid
CAS Number: 102-32-9
Empirical Formula (Hill Notation): C8H8O4
Molecular Weight: 168.15
EC Number: 203-024-1
MDL Number: MFCD00004338
Linear Formula: (HO)2C6H3CH2CO2H
Product Type: Chemical
| assay | 98% |
| form | powder |
| InChI | 1S/C8H8O4/c9-6-2-1-5(3-7( |
| InChI key | CFFZDZCDUFSOFZ-UHFFFAOYSA |
| mp | 127-130 °C (lit.) |
| SMILES string | OC(=O)Cc1ccc(O)c(O)c1 |
| solubility | water: soluble 50 mg/mL, clear, almost colorless |
| Application: | 3,4-Dihydroxyphenylacetic acid may be employed as ligand in the preparation of Mo(VI) complexes. |
| General description: | 3,4-dihydroxyphenylacetic acid (DOPAC) is a normal constituent of rat brain tissue. A mass fragmentographic method for determination of DOPAC in rat brain tissue has been described. It is major metabolite of dopamine (DA). The voltammetric reduction of DOPAC has been studied at a glassy carbon electrode modified with single-wall carbon nanotubes (SWNTs). Semi-automatic fluorometric assay technique for DOPAC has been reported. |
| Other Notes: | 2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research   |
| Packaging: | 1, 5 g in glass bottle |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | 98% |
| mp | 127-130 °C (lit.) |
| UNSPSC | 12352100 |